Correlation of Arterial Blood Gas (ABG) and Venous Blood Gas (VBG) in the Undifferentiated Critically Ill Patient
This study has been completed.
Sponsor:
Christiana Care Health Services
Information provided by (Responsible Party):
Christiana Care Health Services
ClinicalTrials.gov Identifier:
NCT01287884
First received: January 31, 2011
Last updated: November 7, 2012
Last verified: November 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The primary objective of this study is to identify a correlation between the pH and pCO2 in arterial and venous blood. The secondary objectives include a correlation of pulse oximetry and arterial pO2 along with subgroup analyses of specific patient populations such as congestive heart failure, chronic obstructive pulmonary disease, diabetic ketoacidosis, pneumonia, overdose, and trauma.
| Condition | Intervention |
|---|---|
|
Patients Needing Blood Gases |
Other: Venous Blood Gas |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Diagnostic |
| Official Title: | Correlation of Arterial Blood Gas (ABG) and Venous Blood Gas (VBG) in the Undifferentiated Critically Ill Patient |
Resource links provided by NLM:
Further study details as provided by Christiana Care Health Services:
Primary Outcome Measures:
- Degree to which pH and pCO2 correlate between ABG and VBG [ Time Frame: 5 minutes ] [ Designated as safety issue: No ]ABG and VBG will be obtained 5 minutes apart and compared
| Enrollment: | 156 |
| Study Start Date: | October 2010 |
| Study Completion Date: | June 2012 |
| Primary Completion Date: | June 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
No Intervention: Venous Blood Gas
All subjects have an ABG and VBG drawn. No intervention.
|
Other: Venous Blood Gas
patients who have been identified by the treating physician as needing an ABG will receive an VBG is they consent to take part in the study
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Age 18 years or older Signed consent Patient in the ED or ICU Have a disease state that necessitates obtaining an ABG Have a disease state that necessitates pulse oximetry monitoring
Exclusion Criteria:
- Any contraindication to arterial or venous blood draw Prior enrollment in the study during the current hospitalization Pregnancy Prisoners
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01287884
Locations
| United States, Delaware | |
| Christiana Care Health Services | |
| Newark, Delaware, United States, 19718 | |
Sponsors and Collaborators
Christiana Care Health Services
Investigators
| Principal Investigator: | Eli Zeserson, MD | Christiana Care Health Services |
More Information
No publications provided
| Responsible Party: | Christiana Care Health Services |
| ClinicalTrials.gov Identifier: | NCT01287884 History of Changes |
| Other Study ID Numbers: | 600824 |
| Study First Received: | January 31, 2011 |
| Last Updated: | November 7, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Christiana Care Health Services:
|
ABG VBG pH pCO2 |
Additional relevant MeSH terms:
|
Critical Illness Disease Attributes Pathologic Processes |
ClinicalTrials.gov processed this record on May 16, 2013